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Abstract 
Hepatitis B virus (HBV) infection remains a health problem globally despite the availability of 
effective vaccines. In the assembly of the infectious virion, both the preS and S regions of HBV large 
surface antigen (L-HBsAg) interact synergistically with the viral core antigen (HBcAg). Peptides 
preS and S based on the L-HBsAg were demonstrated as potential inhibitors to block the viral 
assembly. Therefore, the objectives of this study were to determine the solution structures of these 
peptides and study their interactions with HBcAg. The solution structures of these peptides were 
solved using 1H, 13C, and 15N NMR spectroscopy. Peptide preS has several structured region of β-
turns at Ser7-Pro8-Pro9, Arg11-Thr12-Thr13 and Ser22-Thr23-Thr24 sequences whereas peptide S 
has only one structured region observed at Ser3-Asn4-His5. Both peptides contain bend-like 
structures surrounding the turn structures. Docking studies revealed both peptides interacted with the 
immunodominant region of HBcAg located at the tip of the viral capsid spikes. Saturation Transfer 
Difference (STD) NMR experiments identified several aromatic residues in peptides preS and S that 
interact with HBcAg. This study provides insights into the contact regions of L-HBsAg and HBcAg at 
atomic resolution which can be used to design antiviral agents that inhibit HBV morphogenesis.   
 
Introduction 
Hepatitis B virus (HBV) is one of the causative agents of liver cirrhosis and hepatocellular 
carcinoma. Currently, it is estimated that there are more than 360 million chronic HBV carriers 
worldwide1, despite the existence of effective vaccines. The emergence of vaccine escape mutants2 
poses a threat to the worldwide vaccination program. An effective therapy for chronic hepatitis B is 
currently unattainable. Clinical treatments involving nucleoside analogues and interferon have limited 
success due to development of drug resistance variants and limited efficacy. The increased number of 
people co-infected with human immunodeficiency virus (HIV) and HBV, particularly in Africa and 
East Asia3 has complicated the processes of drug and vaccine developments against HBV. Therefore, 
HBV infection remains a major worldwide health problem.  
HBV infectious particle is enveloped by a lipid bilayer containing three related surface 
antigens (HBsAg) known as small (S), middle (M) and large (L)-HBsAg. These proteins are 
translated from a single open reading frame using three different in-frame start codons and a common 
stop codon; they therefore share the same 226 amino acids (the whole S-HBsAg) at their C-terminal 
ends. The M-HBsAg contains the S-HBSAg and an N-terminal extension of 55 amino acids known as 
the preS2 region. The L-HBsAg is composed of the entire M-HBsAg with an additional 108 or 119 
residues (depending on the HBV subtype) called the preS1 region. Together, the preS1 and preS2 
regions are known as the preS region. Both the preS and S regions interact with the viral capsid during 
the virus assembly4. The capsid is made of many copies of hepatitis core antigen (HBcAg), a single 
polypeptide containing 183 amino acids5. The C-terminal end of HBcAg is highly rich in positively 
charged amino acids which interact with the viral genome of 3.2 kb6. C-terminal truncated HBcAg 
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mutants without the positively charged residues still assembled into icosahedral capsids in 
Escherichia coli with triangulation number T = 3 and T = 47. However, electron cryomicroscopic 
studies of native HBV virions revealed some differences between the capsids containing nucleic acids 
and the empty capsids produced in E. coli, particularly in the hydrophobic pocket located at the base 
of capsid spikes8,9. The differences in the capsid structures are believed to be important for the 
envelopment of the viral capsids. 
Interactions between L-HBsAg and the viral capsid are critical for the assembly of the virion 
in liver cells10. The preS region of L-HBsAg is exposed on the cytosolic side of endoplasmic 
reticulum, signifying a crucial role for this region in virion assembly by forming docking sites for the 
viral capsid11. A 22-amino acid polypeptide in this region has been identified to play a critical role in 
HBV morphogenesis12. Deletion mutagenesis of the L-HBsAg revealed that a contiguous amino acid 
sequence from Arg92 to Ser113 in the preS region is essential for the interaction with the HBcAg13. In 
addition, a 25-amino acid polypeptide located from Pro56 to Phe80 in the S-HBsAg was demonstrated 
to bind efficiently to HBcAg4. Synthetic peptides correspond to these minimum contact regions in the 
L-HBsAg and S-HBsAg were shown to inhibit the binding of L-HBsAg with HBV capsid with IC50 of 
30 µM and 35 µM, respectively14. Up till now, there is no three dimensional structure of L-HBsAg, 
hence the focus of this study on two independent peptides in the preS and S regions would provide 
insights into the contact regions between L-HBsAg and HBcAg. 
A synthetic peptide with a core motif LLGRMKG which was isolated from a phage displayed 
peptide library against HBV capsids formed by C-terminal truncated HBcAg was demonstrated to 
inhibit the binding of L-HBsAg to HBV capsid with an IC50 of 78 µM15. This peptide was later shown 
to prevent the production of HBV in human hepatoma cells transfected with HBV DNA16. The 
binding of the peptide was located at the immunodominant region of HBcAg. By using cryo-electron 
microscopy and image reconstruction, Seitz et al17 postulated that this peptide blocks the contact 
region between L-HBsAg and HBcAg in HBV virion. These observations suggest that the interaction 
sites of L-HBsAg and HBcAg could serve as a target for anti-HBV inhibitors. 
In order to obtain more information about the contact regions of L-HBsAg and HBcAg, the 
solution structures of the two independent peptides corresponding to the preS and S regions were 
determined by NMR. Interactions of these peptides with HBV capsids formed by C-terminal truncated 
HBcAg were studied by using molecular docking and STD NMR. High resolution structural analysis 
of these peptides would furnish clues to the interactions of these peptides with HBcAg, which 
eventually provides information for designing therapeutic agents that block the assembly of HBV. 
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Results and discussion 
 
Purification of hepatitis B virus core antigen (HBcAg) 
HBcAg was expressed in E. coli and purified using a size exclusion chromatography column 
attached to an FPLC system (Akta Purified, GE Healthcare, USA). The fractions containing HBcAg 
were pooled and concentrated. The concentrated protein was analyzed by SDS-PAGE where an 
intense band of approximately 17 kDa corresponding to the HBcAg monomer was observed (Fig. S1). 
The purity of the HBcAg was 95%. Dynamic Light Scattering revealed that HBcAg self-assembled 
into capsids as described in Yoon et al18. 
 
Chemical shift assignments and identification of secondary structure elements 
Peptide preS has the amino acid sequence RQPTPLSPPLRTTHPQAMHWNSTTF while 
peptide S has the sequence PISNHSPTSCPPTCPGYRWMCLRRF. 1H resonance assignment of 
peptides preS and S was almost completed based on the analysis of 2D proton-proton and proton-
carbon correlated NMR spectra. NH protons of all residues were identified except the N-terminal 
Arg1 of peptide preS and the Pro residues that lack an amide proton. The chemical shifts of the rest of 
the protons were assigned based on 2D TOCSY (Fig. 1), 1H-13C HSQC and 1H-13C HSQC-TOCSY 
spectra. Analysis of these spectra also yielded the resonance assignment of protonated heteroatoms 
(Tables S1 and S2).  
All 15N chemical shifts for peptide preS were assigned, however for peptide S, the last five C-
terminal amino acids could not be assigned because of their very similar HN chemical shifts (Fig. S2). 
In addition, some of the cross peaks of these residues were weak. Strong cross peaks were observed in 
the NOESY spectra corresponding to Hα of the preceding residues to Pro Hδ. These indicated trans 
peptide bonds were present in both preS and S peptides. 
Based on the CSI analysis, the structures of both peptides appear to be close to a random coil 
or a turn structure. Fig. 2A and 2B show that no four successive residues have negative or positive 
CSI values for either peptide, indicating that their structures could not be classified as adopting an α-
helical or β-strand motifs. However, only positive CSI values were returned for peptide preS, which 
implicates that this peptide has a propensity for β-strand like structures. The same applies to the N-
terminal part of peptide S, while its C-terminal part shows a tendency for α-helical structure. The 
analysis of the backbone 3J(HN-Hα) coupling constants confirmed the presence of a random coil 
structure as most of the 3J(HN-Hα) values for both peptides preS and S were in the range of 5-8 Hz 
(Table S3 and S4). 
At 300 K, all Hα to HN NOE of cross peaks were clearly visible allowing sequential resonance 
assignment. Nearly all residues showed strong sequential NOE except for Cys21 of peptide S and the 
proline residues (Fig. 2). However, the sequence of these residues was assigned based on other NOEs, 
including side chain to side chain and HN to HN NOEs. Medium to strong HN to HN  NOEs were 
Page 4 of 21Organic & Biomolecular Chemistry
O
rg
an
ic
&
B
io
m
ol
ec
ul
ar
C
he
m
is
tr
y
A
cc
ep
te
d
M
an
us
cr
ip
t
5 
 
observed in three or more consecutive residues for peptide preS, these NOEs are indicative of a type 
I/I’ β-turn. Nevertheless, long range NOEs were not observed for either peptide, indicating that both 
are unstructured. 
 
Structure determination using restrained molecular dynamics 
A total of 312 and 347 NOE restraints were used in the structure calculation of peptides preS 
and S, respectively. The 3J(HN-Hα) coupling constants obtained from the 2D 1H-15N-HSQC spectra 
were also used as restraint. The structures obtained from the MD trajectories were consistent with the 
criteria chosen for structure calculations, thus these structures were further analyzed and the structural 
ensembles of peptides preS and S were constructed. An ensemble of preS and S consists of ten 
structures that were chosen from each of the top ten most populated clusters. The statistics of the two 
peptides structure ensembles are given in Table 1 with an overlay of the structures shown in Fig. 3A 
and 3B. The φ angles of the peptide ensembles were within the allowed limit from the ideal φ angles 
calculated based on the Karplus curve. Only the φ angles of Leu6 and Ser7 of peptide preS model 
with the most populated cluster deviated 6° and 4° more than the accepted limit, respectively (Table 
S3). While for peptide S, only Ile2 deviated 6° more than the allowed limit (Table S4). However, 
other conformations in preS and S ensembles were within the 30° limit. The Ramachandran plot 
suggests that majority of the residues are in the most favored regions for peptide preS (54%) while 
the residues of peptide S are generally in the additionally allowed region (43%). However, none of the 
residues are in the disallowed regions. Peptide preS sequences that were observed to have medium to 
strong HN to HN NOEs were further analyzed, and they were identified to contain a turn-like structure 
at residues Ser7-Pro8-Pro9 (turn A), Arg11-Thr12-Thr13 (turn B) and Ser22-Thr23-Thr24 (turn C) 
sequences. Based on the phi and psi angles for these amino acids, type I/I’, type IV and type IV turns 
were determined for turn A, turn B and turn C, respectively19. The turns A and B were also 
categorized as potential to form type 310 helical turn as characterized by the NOEs observed at Hα-HN 
for sequence Pro9-Thr12. Furthermore, the turns B and C were in good agreement with the suggested 
HN-HN NOE connectivities observed at these sequences. In addition, residues flanking the turn 
structures can be seen as bend-like, and these bends can be identified clearly in Fig. 3A and 3C. On 
the other hand, the ensemble of peptide S contained only one turn structure at Ser3-Asn4-His5, where 
a type IV turn was determined. HN-HN NOE connectivities were not observed at this sequence, 
however medium strength Hα-HN NOEs were found to connect between Ile2-Ser3 and Asn4-His5. The 
sequences from Ser6-Pro15 and Trp19-Arg23 were classified as bend-like structures since they did 
not fit into a turn-like structure (Fig. 3B and 3D).  
To date, the three dimensional structure of HBsAg, which is the main component of HBV 
envelope, at atomic resolution has not been resolved. On the other hand, the three dimensional 
structures of HBV capsids have been determined using cryo-electron microscopy and X-ray 
crystallography9,20,21,22. The interaction between L-HBsAg and HBcAg, the monomer of HBV capsid, 
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is mediated by two distinct binding sites which are located in the preS and S regions. Therefore, the 
three dimensional structures of peptides preS and S, which correspond to the docking sites in L-
HBsAg and their association with HBcAg capsid may provide insights into the viral morphogenesis 
and development of therapeutic agents that block this process.  
In previous experiments, a comprehensive multi-dimensional NMR study revealed that the 
preS1 domain of L-HBsAg belongs to the family of so-called intrinsically unstructured or intrinsically 
disordered proteins (IDPs). The preS1 domain was shown to contain several local pre-structured 
motifs that are likely to be essential for viral infection but it could not form a stable tertiary 
structure23. The discovery of IDPs has shifted the classical hypothesis towards a more dynamic 
paradigm where a protein can be fully functional even in the absence of a stable, folded structure. 
Particularly when several studies found that many short antigenic peptides undergo a transition from 
an unstructured state to form a β-turn or an α-helix upon binding24,25. 
In this study, the solution structures of peptides preS and S were determined by NMR 
spectroscopy at pH 4. NMR structural studies of proteins and peptides are typically performed at 
slightly acidic conditions (pH 3-6), which enable a better observation of resonances from labile 
protons for instance the backbone amide NHs by minimizing their exchange rates26. Interestingly, in 
our study, both peptides preS and S adopt a random coil ‘turn-like’ structure. Peptide preS containing 
17 C-terminal residues of preS1 region and 8 residues of N-terminal end of preS2 region, was 
observed to have three β-turn structures. Peptide S consisting of amino acids 56-80 of S region was 
found to contain one β-turn.  
 
STD NMR 
HBcAg monomer self-assembles into capsids or virus-like particles (VLPs) is a good 
candidate for STD NMR experiments. STD has no upper limit on the size of the receptor, and favors 
heavier receptor molecules at stronger magnetic fields27. Due to the typically large molecular weight, 
spin diffusion is able to spread the saturation throughout the receptor spectrum and the broad protein 
background signals can be eliminated. Peptide resonances appear in an STD spectrum as a result of 
the transfer of magnetization from the large-molecular-weight protein to a bound small peptide; 
efficient transfer is possible only when the peptide and macromolecular protons are spatially close, it 
also depends on the exchange regime28. In the present study, STD experiments were acquired using 
the parameters described by Rademacher et al29. This technique was applied to study the calicivirus-
ligand interactions. 
To confirm that the STD spectra peaks were not affected by a systematic error, STD 
experiments using the peptides in the absence of HBcAg were also performed and resulted in no 
signals detected. All STD experiments were carried out with buffers at pH 6 due to the stability of the 
HBcAg capsid. In order to identify the 1H resonances in the STD spectra, 1H-1H 2D TOCSY 
experiments were performed at pH 6 for both peptides preS and S. Almost complete assignment of 1H 
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resonances of the free peptides was achieved at pH 6, furthermore the 1H resonances were sufficiently 
resolved to allow unambiguous assignment of the STD spectra. However, quantitative analysis of the 
STD spectra could not be carried out because some of the signals arising from the STD experiments 
were broad and overlapping.   
The STD spectrum of peptide preS with HBcAg capsid revealed significant signal 
enhancements for several 1H of the peptide. The aromatic side chain of residues His14, His19, Trp20 
and Phe25 showed significant STD effects. Furthermore, Arg1HƐ, Met18HƐ, Leu6 and Leu10 Hδ, and 
all Thr Hγ and Hβ similarly showed some signal enhancements (Fig. 4A). The STD spectrum of 
peptide S in the presence of HBcAg capsid also showed STD effects. However, the signals were 
broader than those of preS peptide and overlapping, therefore unambiguous assignment of resonances 
was challenging.  Nevertheless, a few resonances showing significant STD effects were assigned (Fig. 
4B). These 1H included aromatic side chains of Tyr17, Trp19 and Phe25. In addition, Leu22Hδ, Ile2Hγ 
and Hδ, Met20HƐ and Arg24Hη were in close contact with the HBcAg capsid.  
STD spectra obtained from peptides preS and S in the presence of HBcAg capsids indicate 
that both peptides bind to the capsid. Residues Arg1, His14, His19, Trp20, Phe25 of peptide preS and 
residues Ile2, Tyr17, Trp19, Met20, Leu22, Arg24, Phe25 of peptide S, showed signal enhancements. 
These residues appear to play important roles in their interactions with HBcAg capsid, and inhibit L-
HBsAg-HBcAg interactions during the assembly of the infectious virions4,12. Arg1 of peptide preS 
which corresponds to Arg92 of the preS1 domain showed a significant STD signal enhancement.  
Amino acid mutations revealed that Arg92 plays a major role in L-HBsAg-HBcAg interactions13. 
 
Docking studies 
Peptides preS and S were docked to the immunodominant region of HBcAg which is located 
at the tip of HBcAg capsid spikes. Only one peptide was considered for each docking experiment, 
even though both peptides preS and S may interact synergistically with the HBV nucleocapsid. The 
docking of peptides preS and S was centered on the tip of HBV capsid spikes formed by HBcAg 
dimer because previous studies showed that the binding of antiviral peptides at the tip inhibited L-
HBsAg-HBcAg interactions16,30. Furthermore, a cryo-EM map of HBV infectious virions showed that 
the tips of the capsid spikes lay close to the HBsAg9,17. Three structures that formed the ensemble of 
structures for both peptides preS and S were docked to HBcAg dimers with the PDB code 3KXS31 
and 1QGT21 using HADDOCK. Two 3D structures of HBcAg were chosen in order to compare 
docking of the structure of dimers that do not assemble into a capsid (3KXS) and the structure of 
dimers that form a capsid (1QGT). The three representative structures of the peptides were obtained 
from the clusters with the highest number of trajectories. Docking of the first model of peptide preS 
ensemble to HBcAg AB dimer of  PDB 3KXS produced 6 clusters while peptide S produced 11 
clusters. A Z-score of -1.4 and -2.3 was obtained for peptides preS and S, respectively, from the best 
HADDOCK cluster. Docking of the first model of peptide preS to CD dimer produced 10 clusters and 
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a Z-score of -1.6 while peptide S produced 6 clusters and a Z-score of -1.3 (Fig. 5).  A Z-score of -1.6 
and -1.7 was obtained for peptides preS and S, respectively, when docked to EF dimer. The peptides 
appear to interact with both monomers of each dimer, AB, CD and EF at the tips of HBcAg capsid 
spikes.  
Hydrogen bonds and hydrophobic contacts between the peptides and HBcAg were analyzed 
by Ligplot. Analysis of all binding modes of peptide preS docked to the three dimers of PDB 3KXS 
showed that residues Arg1, Gln2, Leu6, Thr13, Met18, Thr24 and Phe25 contributed to the interaction 
with HBcAg. In addition, both His14 and His19 were involved in hydrogen bonding. Similarly, a 
number of aromatic and polar amino acids of peptide S were found to be hydrogen bonded to the 
HBcAg. These residues included His5, Ser6, Ser9, Trp19 and Phe25. Residues Arg18, Arg23 and 
Arg24 were found to contribute to the hydrogen bonding interaction as well. Several binding modes 
produced by HADDOCK for peptide S showed that residues Ile2, Met20 and Leu22 were also 
hydrogen bonded to HBcAg.     
Docking of the first model of peptide preS ensemble to HBcAg AB dimer of PDB 1QGT 
produced 6 clusters while peptide S produced 12 clusters. A Z-score of -1.4 and -1.7 was obtained for 
peptides preS and S, respectively. Ligplot analysis showed that almost similar residues of peptides 
preS and S were involved in hydrogen bonding and hydrophobic contacts with the HBcAg dimer of 
1QGT when compared to the docking of the peptides with  HBcAg dimers of PDB 3KXS. These 
residues include Arg1, Leu6, Thr12, Met18, His19, Trp20 and Thr23 for peptide preS, and 2Ile, His5, 
Thr8, Ser9, Cys10, Tyr17, Arg18, Trp19 and Cys21 for peptide S.    
The immunodominant region (amino acids 74-84) of HBcAg seems to play an important role 
in the interaction of the peptides with HBcAg. Amino acids Asn75, Glu77, Asp78 and Ser81 in the 
immunodominant region were involved in hydrogen bonding with both peptides in all of the 
complexes analyzed using both the HBcAg dimers of PDB 3KXS and 1QGT. Whereas, residues 
Ala80 and Asp83 from HBcAg dimers AB and EF of PDB 3KXS interact with peptide preS, while 
residue Thr74 from dimers AB and CD was found to interact with peptide S by hydrogen bond 
interaction. Residues Leu76, Glu77, Asp78, Pro79, Ala80, Ser81 and Leu84 were involved in 
hydrophobic interaction with both peptides preS and S in the majority of the binding modes analyzed. 
In another study, Ponsel and Bruss32 demonstrated that mutations of 11 amino acids (Ser17, Phe18, 
Leu60, Leu95, Lys96, Phe122, Ile126, Arg127, Asn136, Ala137, and Ile139) which are located 
around the base of the capsid spike and in a small area close to the pores in the capsid, did not inhibit 
nucleocapsid formation but blocked particle envelopment and virion formation. These residues were 
therefore postulated to interact with HBsAg during virion morphogenesis. By using an in vitro assay, 
Tan et al13 revealed that at least two distinct elements within a large area of L-HBsAg interacted 
synergistically with HBcAg. One element is located between residues 24-191 and the other between 
residues 191-322 of L-HBsAg. In the present study, peptide preS which lies in the first element and 
peptide S which is located in the N-terminal end of the second element (residues 191-263) were found 
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to dock at the tip of capsid spike. However, binding of the C-terminal end of the second element 
(residues 263-322) with HBcAg was not investigated in the present study. The residues in the C-
terminal end of the second element may interact with other regions on the surface of the capsid and 
mediate the assembly of the virion.    
Docking studies showed that residues Arg1, Gln2, Leu6, Thr13, Met18, Thr24 and Phe25 of 
peptide preS, which correspond to residues Arg92, Gln93, Leu97 and Thr104 of the preS1 domain 
and Met1, Thr7 and  Phe8 of the preS2 domain interacted with residues Asn75, Glu77, Asp78 and 
Ser81 of HBcAg. Whereas residues His5, Ser6, Ser9, Arg18, Trp19, Arg23, Arg24 and Phe25 of 
peptide S which correspond to residues His60, Ser61, Ser64, Arg73, Trp74, Arg78, Arg79 and Phe80 
of S-HBsAg, were found to interact with the HBcAg capsid spike. These findings are in good 
agreement with the STD results where the residues that form the hydrogen bonding network are 
spatially close to the HBcAg based on the STD spectra obtained. The similar residues are Arg1, 
Thr13, Met18, Thr24 and Phe25 of peptide preS, and residues Ile2, Trp19, Met20, Leu22, Arg24 and 
Phe25 of peptide S.  In general, most of the residues in peptides preS and S interacted at the tip of 
capsid spikes. This is in good agreement with earlier findings showing different segments and 
protrusions of HBsAg interacted at the tips of capsid spikes formed by two conformations of HBcAg 
dimers17. 
 
Conclusions 
The conformations of peptides preS and S can be categorized as disordered structures, 
stabilized by the presence of β-turn motifs. The adaptability of the disordered structures may play an 
important role in L-HBsAg as a dual-functional protein that involves in virion assembly and entry into 
host cells. STD NMR experiments of the peptides in the presence of HBcAg capsid identified residues 
in close contact with the tips of capsid spikes. The STD results are supported by the computational 
model of the complex formed between the solution structures of the peptides with the HBcAg dimer. 
Favorable interactions uncovered by the docking studies include hydrogen bonds and hydrophobic 
contacts observed between the peptides and the tips of capsid spikes provide useful information for 
designing inhibitors that block HBV morphogenesis. 
 
Experimental 
 
Purification of hepatitis B virus core antigen 
E. coli strain harboring the plasmid pR1-11E which encodes HBcAg (residues 3-148) was 
grown in Luria Bertani broth as previously described30. The cells were harvested and lysed by 
sonication. HBcAg in lysate was precipitated with ammonium sulfate and the sample was dialyzed 
with two changes in 50 mM Tris-HCl (pH 8), 100 mM NaCl buffer. The dialyzed HBcAg was 
purified by size exclusion chromatography (SEC)18 using Sephacryl-500 (GE Healthcare) packed in 
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an XK 16/100 column (Amersham, USA). Fractions containing the HBcAg were collected, pooled 
and concentrated using 300 kDa cut-off Vivaspin (Sartorius Stedim Biotech, Germany) concentrator 
by centrifugation. The concentrated proteins were analyzed on SDS-PAGE33 and the final 
concentration of the purified HBcAg was determined using the Bradford assay34. The formation of 
HBcAg capsid was confirmed by dynamic light scattering (Dyna Pro-801TM, Protein Solution Ltd. 
High Wycombe, UK) as described by Yoon et al18. 
 
Peptide synthesis 
Two peptides, preS and S, derived from the sequence of HBsAg (adyw subtype) were 
synthesized using the Fmoc solid phase peptide chemistry (Genemed Synthesis Inc., USA).  Peptide 
preS has the amino acid sequence RQPTPLSPPLRTTHPQAMHWNSTTF (17 residues of the C-
terminal preS1 region + 8 residues of the N-terminal preS2 region) while peptide S has the sequence 
PISNHSPTSCPPTCPGYRWMCLRRF (residues 56-80 of the S region of HBsAg). The peptides were 
analyzed by HPLC and mass spectrometry. 
 
NMR spectroscopy 
All NMR experiments were performed at 300 K using a Bruker Avance III 800 MHz 
spectrometer equipped with a TCI cryoprobe. The peptides were dissolved in 550 L of sodium 
phosphate (20 mM) in 90% H2O/10% D2O, and the pH was adjusted from 4.0 to 6.0 with the peptide 
concentrations from 3 mM to 6 mM. Proton chemical shifts were referenced relative to the H2O offset 
frequency (4.705 ppm at 27 °C) and heteronuclear chemical shifts were referenced relative to the 
proton frequency using the method of Wishart et al35. 1H-1H 2D NMR TOCSY and NOESY 
experiments were carried out using the DPFGSE for water-suppression36. TOCSY spectra were 
acquired using mixing times of 20 ms and 80 ms, while NOESY spectra were recorded using mixing 
times of 150 ms. The spectral width was typically 9500 Hz with acquisition time of 0.21 s. 2D 1H-13C-
HSQC and 1H-13C HSQC-TOCSY spectra were also collected to assist in 1H chemical shift 
assignments. Acquisition data were sampled with 2048 x 1536 complex points in the t2 and t1 
dimensions. In addition, 2D 1H-15N-HSQC spectrum was acquired with 8192 x 256 complex points in 
the t2 and t1 dimensions to assist in backbone torsion angle calculations. The torsions were derived 
from the 3J(HN-Hα) coupling constants extracted from the 2D 1H-15N-HSQC spectrum acquired 
without the refocusing of signals and 15N decoupling. Dihedral angles (φ) were calculated using the 
Karplus equation37. 
 
Spectral assignment 
NMR data were processed in the TopSpin3.2 Bruker BioSpin GmbH, Germany and analyzed 
using the CCPNmr Analysis 2.338. 1H, 13C, and 15N chemical shifts of the backbone and side-chains 
nuclei were obtained by analyzing the 2D spectra. The assignment of the chemical shifts for peptides 
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preS and S was performed using the spectra obtained with peptides in pH 4 and 6. A combination of 
2D 1H-13C HSQC and 1H-13C HSQC-TOCSY spectra was required to assign unambiguously all 
resonances. The 2D 1H-13C HSQC-TOCSY spectrum was particularly useful in confirming the 
chemical shifts of 1H of the peptides. All aliphatic 1H resonances were assigned unambiguously since 
most of the cross peaks were well resolved. Sequential assignment of the amino acids of both peptides 
was performed using the NOESY spectra. The fingerprint region of the spectra was particularly 
helpful since NOEs between NH(i) and Hα(i-1) were easily assigned. In addition, the assignment of 
the NOESY spectrum provided distance restraints information based on the volume of the cross peaks 
calculated by CCPNmr Analysis and each NOE cross peak was examined manually. The CSI values 
were also calculated by CCPNmr Analysis using the difference of the recorded chemical shift to 
random coil chemical shift of Cα, Cβ, C’ and Hα atoms39,40. These secondary chemical shifts were 
combined to give the CSI values indicating the type of secondary structure, where -1 indicates alpha-
helix and +1 indicates beta-strand.   
 
Structure calculations 
NMR-restraint molecular dynamics (MD) simulations were performed using the AMBER 
1241 program by incorporating NOE restraints (Tables S5 and S6) and backbone 3J(HN-Hα) coupling 
constants (Tables S3 and S4). The input files of the restraints were obtained from the assignment of 
the spectra for peptides preS and S in pH 4. NOE cross-peaks were converted into distances based on 
an r-6 dependence and calibration was performed using the default setting of an average peak 
intensity that corresponded to a distance of 3.2 Å. The initial starting structure was randomly drawn 
using the Avogadro software42 and heated to 600 K then cooled down to 300 K for 20 ps in vacuo, in 
order to relax the structure. The structures were then soaked in a waterbox and were first minimized 
and heated to 300 K, followed by a MD simulation for 500 ps. A total of 5000 structures were 
generated. The stability of the simulation was monitored by observing the backbone RMSD values. 
The clustering facility43 in the Chimera software was initiated during 100 ps until 300 ps of the MD 
simulation. The clusters were obtained based on the backbone atoms of the peptide in a pairwise 
manner. Top ten clusters that contained the highest number of trajectories were further analyzed by 
selecting the trajectories with the following conditions (i) the structure has φ angles within 30o of the 
φ-values calculated from 3J(HN-Hα), and (ii) the structure has an interproton distance error < 0.5 Å 
compared to the upper boundaries of distances derived from the NOE restraints44. One conformation 
from each of the top ten clusters that suited the above criteria was then selected to form a structural 
ensemble and analyzed using the PROCHECK-NMR45. The PyMOL (Version 1.3 Schrödinger, LLC) 
and the Discovery Studio Visualizer 3.5 (Accelrys) were used to view the structural ensembles. 
PyMOL was also utilized to measure the distances of the protons included in the NOE restraints and 
the dihedral angles of the peptide structure ensembles. 
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Saturation transfer difference (STD) experiments  
All STD spectra were recorded at 300 K using a Bruker Avance III 800 MHz spectrometer 
equipped with a TCI cryprobe. The solvent used was 20 mM sodium phosphate (pH 6), 150 mM 
NaCl. The peptides and the HBcAg capsid samples were prepared in 9:1 H2O:D2O buffer using 200 
µM peptides, while the HBcAg concentration ranged from 16 nM to 32 nM. The final concentration 
of the HBcAg capsid was adjusted to 32 nM. A 6.25 molar excess of peptides was used for all STD 
experiments when compared to the monomeric HBcAg.  Typically, STD NMR experiments are 
performed in 100% D2O to achieve sufficient magnetization transfer from protein to ligand. However, 
in this study a ratio of 9:1 H2O:D2O buffer at pH 6 was used, thus suppression of residual water signal 
was done using the Watergate 3-9-19. 1D STD spectra were acquired by subtracting an on-resonance 
FID, with selective saturation of protein resonance at -4 ppm, from an off-resonance FID, with 
saturation at -300 ppm. Subtraction of the two spectra by phase cycling leads to the difference 
spectrum that contains signals arising from the saturation transfer. The acquisition and relaxation 
times were 0.68 and 6 s, respectively. The saturation was achieved by five Gaussian pulses with 
duration of 80 ms. The total number of scans was fixed at 32 with 4 dummy scans and a typical 
spectra width of 16 ppm.  
 
Molecular docking 
Docking of the HBcAg dimer with peptides preS and S was accomplished using 
HADDOCK46. The WeNMR grid-enabled server47 was utilized to perform the docking simulations. 
Crystal structures of HBcAg trimer of dimer with the PDB code 3KXS31 and a dimer of 1QGT21 were 
docked with the peptides. Three dimers, AB, CD and EF of PDB 3KXS structure and AB dimer of 
PDB 1QGT were each employed for docking with the peptides. The active residues of the protein 
were fixed around the spike of the HBcAg (aa 72 – 88) dimer whereas all of the amino acids of the 
peptides were selected as active residues. The docked complex structure produced by the HADDOCK 
was based on the Z-score, therefore the cluster with the lowest Z-score value was chosen as the most 
reliable docked structure of the peptides to the protein. The LigPlot program48 was employed to 
analyze the docking results. 
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Figures  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1   2D 1H-1H TOCSY spectra of peptides preS and S. The NH regions of preS (A) and S (B) of 
the spectra are shown. All NH protons were assigned for both peptides except the N-terminal NH and 
Pro residues. 
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Fig. 2   A summary of the inter-residue NOEs and chemical shift index (CSI). The CSI values for 
peptides preS (A) and S (B) shown as thin straight lines were equal to 0 or were not calculated. The 
CSI is based on the analysis of 1Hα, 13Cα and 13Cβ chemical shifts. Thickness of the bars for the NOEs 
represents relative strength (strong, medium, weak). 
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Fig. 3 Overlay of ten NMR restrained MD structures and the representative structures of peptides. 
Backbone of the ten structure ensembles of peptides preS (A) and S (B) are rendered as ribbons. 
Representative structures of peptides preS (C) and S (D) rendered as sticks and the backbone as 
cartoons. The dotted lines indicate the medium range NOEs and their distance.   
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Fig. 4 STD spectra of peptides preS and S in the presence of HBcAg capsid. The 1D 1H reference 
spectra of peptides preS (A) and S (B) in the presence of HBcAg capsid are shown in red. The STD 
spectra of the peptides in the presence of HBcAg capsid with on-resonance irradiation at -4 ppm are 
shown in blue. 1H resonances arising from the STD experiments are labeled.  
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Fig. 5 Peptides in complex with HBcAg. A close-up of peptides preS (A) and S (C) docked at the tip 
of the HBcAg capsid spike. The complex generated by HADDOCK with the lowest Z-score cluster 
was chosen as representation of docked structures. Peptides and the immunodominant region of 
HBcAg are rendered as sticks while transparent surface with secondary structure element rendered as 
ribbon indicating the HBcAg CD dimer of PDB 3KXS. HBcAg monomer C is in orange whereas 
monomer D is in light orange. Figure 5B shows the structures of  HBcAg AB (blue), CD (yellow) and 
EF (green) dimers of PDB 3KXS, and HBcAg AB (orange) dimer of PDB 1QGT as secondary 
structure elements. The circled region is the immunodominant region of HBcAg.   
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Tables 
Table 1. Structural statistics of the simulated peptide ensembles of preS and S 
Parameter preS S 
Distance restraints   
All 312 348 
Intra-residue 199 240 
Inter-residue   113 108 
Sequential (i,i+1) 96 87 
Long range (i>=i+2)  13 19 
RMSD   
Average heavy atom RMSD to most populated 
cluster conformation  
1.1 0.8 
Average backbone RMSD to most populated cluster 
conformation 
0.9 0.4 
Ramachandran Plot   
Residues in most favored region 54.44% 43.33% 
Residues in additional allowed regions 45.56% 54.45% 
Residues in generously allowed regions 0% 2.22% 
Residues in disallowed regions 0% 0% 
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